Avid Bioservices, Inc.
CDMOFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
4/30/2024
Revenue
140
Cost of Revenue
133
Gross Profit
7
Gross Margin
5.2%
Operating Income
-19
Operating Margin
-13.3%
Net Income
-141
Net Margin
-100.6%
EPS (Basic)
$-2.23
EPS (Diluted)
$-2.23
EBITDA
-11
EBITDA Margin
-8.2%
2023
4/30/2023
Revenue
149
Cost of Revenue
118
Gross Profit
31
Gross Margin
21.1%
Operating Income
-3
Operating Margin
-1.7%
Net Income
1
Net Margin
0.4%
EPS (Basic)
$0.01
EPS (Diluted)
$0.01
EBITDA
11
EBITDA Margin
7.3%
2022
4/30/2022
Revenue
120
Cost of Revenue
83
Gross Profit
37
Gross Margin
30.6%
Operating Income
11
Operating Margin
9.1%
Net Income
128
Net Margin
106.8%
EPS (Basic)
$2.08
EPS (Diluted)
$1.81
EBITDA
20
EBITDA Margin
16.6%
2021
4/30/2021
Revenue
96
Cost of Revenue
67
Gross Profit
29
Gross Margin
30.6%
Operating Income
9
Operating Margin
9.3%
Net Income
11
Net Margin
11.7%
EPS (Basic)
$0.06
EPS (Diluted)
$0.06
EBITDA
16
EBITDA Margin
16.4%
2020
4/30/2020
Revenue
60
Cost of Revenue
56
Gross Profit
4
Gross Margin
6.6%
Operating Income
-11
Operating Margin
-17.7%
Net Income
-7
Net Margin
-12.2%
EPS (Basic)
$-0.13
EPS (Diluted)
$-0.13
EBITDA
-7
EBITDA Margin
-12.4%